Role of Vitamin D in Uremic Vascular Calcification

Area of Science:

• Nephrology
• Cardiology
• Endocrinology

Background:

• Patients with chronic kidney disease (CKD) face a significantly elevated risk of cardiovascular death, approximately 10 times higher than individuals without CKD.
• Vascular calcification is a prevalent complication in CKD patients and a key predictor of cardiovascular mortality.
• Vitamin D deficiency is common in CKD and is closely linked to the progression of vascular calcification.

Purpose of the Study:

• To investigate the protective role of vitamin D supplementation in mitigating vascular calcification in patients with chronic kidney disease (CKD).
• To explore the mechanisms by which vitamin D influences cardiovascular health and vascular calcification in the context of CKD.

Main Methods:

• Review of existing literature on vitamin D, CKD, and cardiovascular complications.
• Analysis of the impact of GFR decline, proteinuria, and tubulointerstitial injury on vitamin D status and its effects.
• Examination of the proposed mechanisms of vitamin D's action on vascular calcification.

Main Results:

• Vitamin D supplementation demonstrates a protective effect on vascular calcification in CKD patients by influencing the endothelium.
• Key mechanisms include renin-angiotensin-aldosterone system inactivation, improved insulin resistance, cholesterol reduction, and modulation of vascular regeneration.
• Vitamin D also aids in managing arterial calcification by reducing proteinuria, reversing renal osteodystrophy, and restoring calcification inhibitors.

Conclusions:

• Vitamin D supplementation may serve as an ancillary therapy to ameliorate uremic vascular calcification in CKD patients.
• Emerging evidence suggests vitamin D may play a role in modulating adventitial progenitor cells involved in vascular calcification.
• Further research into vitamin D's pleiotropic effects is warranted for cardiovascular risk management in CKD.